| First Published on Clinicaltrials.gov: |
7/27/2005 |
| Status: |
This study has been completed |
| ClinicalTrials.gov ID: |
NCT00125203 |
| Sponsor: |
The University of Texas Health Science Center at San Antonio |
| Purpose: |
The purpose of this study is to determine the safety and efficacy of Myobloc in ALS patients who are having excessive drooling. |
| Phase: |
II/III |
| Treatment Type: |
Injection |
| Trial Type: |
Double Blind, Placebo Controlled |
| Estimated Enrollment: |
20 |
| Eligibility: |
21 to 85 years. Both genders. No healthy volunteers. |
| Details: |
The primary goal of the study is to determine if the patient perceives a benefit from the Myobloc in controlling excessive drooling. |
| Collaborator(s): |
|
| Location(s): |
- Kansas City, KS, 66160, United States
- Charlotte, NC, 28203, United States
|
| Primary Investigator: |
Carlayne E Jackson, MD and Charles B Simpson, MD- University of Texas Health Science Center at San Antonio |
| Contact: |
|
| Trial Protocol as Published on Clinicaltrials.gov: |
|
| ALS Forum: |
|